AIRLINK 188.50 Decreased By ▼ -8.15 (-4.14%)
BOP 10.17 Increased By ▲ 0.03 (0.3%)
CNERGY 6.61 Decreased By ▼ -0.08 (-1.2%)
FCCL 34.03 Increased By ▲ 1.01 (3.06%)
FFL 16.60 Decreased By ▼ -0.05 (-0.3%)
FLYNG 24.16 Increased By ▲ 1.71 (7.62%)
HUBC 126.20 Decreased By ▼ -1.09 (-0.86%)
HUMNL 13.82 Decreased By ▼ -0.08 (-0.58%)
KEL 4.82 Increased By ▲ 0.06 (1.26%)
KOSM 6.50 Increased By ▲ 0.13 (2.04%)
MLCF 43.19 Increased By ▲ 0.97 (2.3%)
OGDC 213.00 Decreased By ▼ -0.03 (-0.01%)
PACE 7.30 Increased By ▲ 0.29 (4.14%)
PAEL 42.19 Increased By ▲ 1.32 (3.23%)
PIAHCLA 17.47 Increased By ▲ 0.65 (3.86%)
PIBTL 8.43 Increased By ▲ 0.14 (1.69%)
POWER 9.00 Increased By ▲ 0.18 (2.04%)
PPL 184.90 Increased By ▲ 1.33 (0.72%)
PRL 38.02 Decreased By ▼ -0.25 (-0.65%)
PTC 24.25 Increased By ▲ 0.18 (0.75%)
SEARL 94.75 Decreased By ▼ -0.36 (-0.38%)
SILK 1.00 No Change ▼ 0.00 (0%)
SSGC 39.60 Decreased By ▼ -0.71 (-1.76%)
SYM 17.89 Decreased By ▼ -0.32 (-1.76%)
TELE 8.73 No Change ▼ 0.00 (0%)
TPLP 12.50 Increased By ▲ 0.29 (2.38%)
TRG 63.90 Decreased By ▼ -0.46 (-0.71%)
WAVESAPP 10.50 Increased By ▲ 0.06 (0.57%)
WTL 1.79 No Change ▼ 0.00 (0%)
YOUW 3.98 Decreased By ▼ -0.02 (-0.5%)
BR100 11,721 Decreased By -1.9 (-0.02%)
BR30 35,442 Increased By 83 (0.23%)
KSE100 113,073 Increased By 434.6 (0.39%)
KSE30 35,576 Increased By 117.9 (0.33%)

A non-prescription hormonal supplement sometimes marketed as a "fountain of youth" drug may be effective in combating mid-life depression, doctors said on Monday. The drug DHEA - dehydroepiandrosterone - "may have a useful role in the treatment of mild to moderately severe midlife-onset major and minor depression" in some patients, said the report from the National Institute of Mental Health.
The findings were based on a small study involving 46 men and women aged 45 to 65 who had major or minor depression of moderate severity.
Some were given the drug and others an inert placebo, and the process was repeated switching the drug and no-drug groups. At the end the participants were measured by standard tests for depression.
In all, 23 showed a reduction of at least 50 percent in their depression after they received the drug. In addition, 13 showed improvement after the placebo.
The report was published in the Archives of General Psychiatry.
The authors said since only half of those studied found improvement with the drug and it is not clear why or for whom it best works, a more conventional anti-depression drug would likely the first choice for treatment.

Copyright Reuters, 2005

Comments

Comments are closed.